Recombinant human activated protein C (rhAPC, drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia - Derhaschnig, U; Reiter, R; Knöbl, P (Blood, 2003)
et al.